| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |